Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
https://www.youtube.com/watch?v=EovAbEytb5Q
^Pls support my channel
English version> financial analysis for Dpharm.
Analysis on income statement, balance sheet, cash flow statement and prospects.
Looking good. Looking forward to the QR, with a continuous strengthening of MYR, everything is still looking bright other than the share price (bot manipulation)
Can you all see how Dpharma is controlled now? With just a few hundred k shares volume a day they can press it down just enough to break previous low, and they can pull it back up effortlessly with just 1-2 million volume . This is left to right hand, right to left hand game
1.41 today. Short timeframe breakout. Fake breakout or real? Dpharma must stand firmly above 1.4 on a technical perspective , but bots manipulation make it tricky to catch
Quap: imo, pharmaceutical companies generally manufacture medicines based on supply and demand (which is quite constant). Under normal circumstances, writing off expired medicines is not a major issue. However, in Pharmaniaga’s case, it was a one-off incident — they misjudged the duration of covid and ended up purchasing excessive stock.
